Supplemental Table S4 from Clonal Hematopoiesis in Young Women Treated for Breast Cancer par Christopher J. Gibson (15907642)

Autres auteurs:

Supplemental Table S3 from Clonal Hematopoiesis in Young Women Treated for Breast Cancer par Christopher J. Gibson (15907642)

Autres auteurs:

Figure S1 from Targeting MET and FGFR in Relapsed or Refractory Acute Myeloid Leukemia: Preclinical and Clinical Findings, and Signal Transduction Correlates par Evan C. Chen (15054014)

Autres auteurs:

Figure S3 from Targeting MET and FGFR in Relapsed or Refractory Acute Myeloid Leukemia: Preclinical and Clinical Findings, and Signal Transduction Correlates par Evan C. Chen (15054014)

Autres auteurs:

Figure S4 from Targeting MET and FGFR in Relapsed or Refractory Acute Myeloid Leukemia: Preclinical and Clinical Findings, and Signal Transduction Correlates par Evan C. Chen (15054014)

Autres auteurs:

Figure S2 from Targeting MET and FGFR in Relapsed or Refractory Acute Myeloid Leukemia: Preclinical and Clinical Findings, and Signal Transduction Correlates par Evan C. Chen (15054014)

Autres auteurs:

Figure S6 from Targeting MET and FGFR in Relapsed or Refractory Acute Myeloid Leukemia: Preclinical and Clinical Findings, and Signal Transduction Correlates par Evan C. Chen (15054014)

Autres auteurs:

Figure S5 from Targeting MET and FGFR in Relapsed or Refractory Acute Myeloid Leukemia: Preclinical and Clinical Findings, and Signal Transduction Correlates par Evan C. Chen (15054014)

Autres auteurs: